Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5192425
Max Phase: Preclinical
Molecular Formula: C21H25N5O
Molecular Weight: 363.47
Associated Items:
ID: ALA5192425
Max Phase: Preclinical
Molecular Formula: C21H25N5O
Molecular Weight: 363.47
Associated Items:
Canonical SMILES: CCc1c(C)nc2c(C(=O)N3CCN(c4ccccc4)CC3)cnn2c1C
Standard InChI: InChI=1S/C21H25N5O/c1-4-18-15(2)23-20-19(14-22-26(20)16(18)3)21(27)25-12-10-24(11-13-25)17-8-6-5-7-9-17/h5-9,14H,4,10-13H2,1-3H3
Standard InChI Key: QHPKMGVTOJFXMN-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 363.47 | Molecular Weight (Monoisotopic): 363.2059 | AlogP: 2.87 | #Rotatable Bonds: 3 |
Polar Surface Area: 53.74 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 3.43 | CX LogP: 2.98 | CX LogD: 2.98 |
Aromatic Rings: 3 | Heavy Atoms: 27 | QED Weighted: 0.72 | Np Likeness Score: -2.09 |
1. Zhang G, Wang F, Li S, Cheng KW, Zhu Y, Huo R, Abdukirim E, Kang G, Chou TF.. (2022) Discovery of small-molecule inhibitors of RUVBL1/2 ATPase., 62 [PMID:35364523] [10.1016/j.bmc.2022.116726] |
Source(1):